Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

September 2026

Added to Dediabetes Sep 12, 2026RCTs

Resistance exercise improves compliance in pregnant women with GDM.

This study compared resistance exercise and aerobic exercise in pregnant women with gestational diabetes, finding significant differences in postprandial blood glucose levels.

Interventions
Aerobic exerciseTaichi plus resistance band training
Outcomes
Fasting Plasma Glucose (FPG)Incidence of adverse pregnancy outcomesInsulin utilization rate+1 more
Added to Dediabetes Sep 12, 2026RCTs

Toe Resistance Training Improves Strength in Diabetes Patients

This study investigated the effects of resistance training on toe pinch force in chronic hemodialysis patients with type 2 diabetes, finding significant improvements in the intervention group.

Interventions
Aerobic exerciseResistance training
Outcomes
Rate of Continuation of Exercise TherapyToe Pinch Force (TPF)
Added to Dediabetes Sep 12, 2026RCTs

Semaglutide and Canagliflozin show similar effects on body composition

This study compared the effects of Semaglutide and Canagliflozin on body composition in adults with Type 2 Diabetes, finding greater reductions in fat and lean mass with Semaglutide.

Interventions
CanagliflozinSemaglutide
Outcomes
Body fat massLean body massPercentage change in visceral fat mass
Added to Dediabetes Sep 12, 2026RCTs

Semaglutide enhances insulin response in type 2 diabetes

The study evaluated the effects of semaglutide on beta cell function and glycaemic control in type 2 diabetes, finding significant improvements in insulin secretion and glucose levels.

Interventions
Subcutaneous Semaglutide
Outcomes
Fasting Plasma Glucose (FPG)Glucagon response (AUC 0-24h)Glucose iAUC (OGTT)+3 more
Added to Dediabetes Sep 12, 2026RCTs

Dulaglutide improves HbA1c more than insulin glargine in T2D

This study compared once-weekly dulaglutide with daily insulin glargine in Asian patients with type 2 diabetes, finding dulaglutide resulted in greater HbA1c reductions.

Interventions
DulaglutideInsulin glargine once daily
Outcomes
Body weightGastrointestinal disorders incidenceHbA1c+2 more
Added to Dediabetes Sep 12, 2026RCTs

Combination Therapy Reduces HbA1c and Weight in Type 2 Diabetes

This study evaluated the effects of exenatide once weekly combined with dapagliflozin on HbA1c and body weight in adults with type 2 diabetes, finding significant reductions in both measures.

Interventions
DapagliflozinExenatideExenatide once weekly plus dapagliflozin
Outcomes
Body weightHbA1c
Added to Dediabetes Sep 12, 2026RCTs

Semaglutide maintains glucagon response during hypoglycaemia.

The study evaluated the impact of semaglutide on glucagon response during hypoglycemia in individuals with type 2 diabetes, finding no significant compromise in glucagon levels.

Interventions
Semaglutide
Outcomes
Cognitive functionGlucagonHypoglycemia symptom score+2 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.